Wellness Focus Cayman Islands
SEE OTHER BRANDS

Get your health and wellness news from the Cayman Islands

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Wellness Focus Cayman Islands.

U.S. Imposes Additional 25% Tariff on Indian Goods Amid Rising Trade Pressures

U.S. Imposes Additional 25% Tariff on Indian Goods Amid Rising Trade Pressures

As the Reserve Bank of India holds its benchmark rate at 5.5%, EBC Financial Group warns India’s external outlook may face greater pressure in the months ahead. INDIA, August 8, 2025 /⁨EINPresswire.com⁩/ -- U.S. President Donald Trump announced on...

Miss World Cayman Islands 2024-2025: Celebrating Purpose and Beauty Beyond the Surface

Miss World Cayman Islands 2024-2025: Celebrating Purpose and Beauty Beyond the Surface

Grand Cayman, Cayman Islands , Sept. 25, 2024 (GLOBE NEWSWIRE) -- Caymanian Entrepreneur and Director of Miss World Cayman Islands, Pamela Ebanks-Small is flipping the narrative. “This is a unique opportunity for local and global businesses to be...

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity…

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity…

Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) announce the signing of an agreement and plan of merger for a...

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) announce the signing of an agreement and plan of merger for a...

Silexion Therapeutics Announces 1-for-15 Reverse Share Split

Silexion Therapeutics Announces 1-for-15 Reverse Share Split

Grand Cayman, Cayman Islands, July 16, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers,...

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and Contribution and Share Exchange Agreement (the “Merger Agreement”) regarding a business...

Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination

Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination

Wilmington, DE, July 28, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date...

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

ZURICH, SWITZERLAND, July 17, 2025 -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands exempted company and special purpose acquisition company...

David Barrett, CEO of EBC Financial Group (UK) Ltd and EBC Financial Group (Cayman) Limited, Analyses Global Market Volatility, High-Interest Rate Pressures, and Safe-Haven Investment Strategies Amid 2024 Economic Shifts

David Barrett, CEO of EBC Financial Group (UK) Ltd and EBC Financial Group (Cayman) Limited, Analyses Global Market Volatility, High-Interest Rate Pressures, and Safe-Haven Investment Strategies Amid 2024 Economic Shifts

LONDON, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Global markets are in a state of flux as inflationary pressures, shifting interest rate policies, and geopolitical tensions converge to create unprecedented uncertainty across financial sectors. David...

Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines

Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines

Grand Cayman, Cayman Islands, July 09, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers,...

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands exempted company and special purpose acquisition...

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025 NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact...

European Central Bank Holds Rates in Tactical Pause as Global Trade Frictions and Market Paths Diverge

European Central Bank Holds Rates in Tactical Pause as Global Trade Frictions and Market Paths Diverge

With inflation on target but volatility mounting, EBC Financial Group says the ECB’s pause reflects a critical inflection point for Europe’s monetary strategy. DC, UNITED STATES, July 28, 2025 /⁨EINPresswire.com⁩/ -- The European Central Bank...

European Central Bank Holds Rates in Tactical Pause as Global Trade Frictions and Market Paths Diverge

European Central Bank Holds Rates in Tactical Pause as Global Trade Frictions and Market Paths Diverge

With inflation on target but volatility mounting, EBC Financial Group says the ECB’s pause reflects a critical inflection point for Europe’s monetary strategy. DC, UNITED STATES, July 28, 2025 /⁨EINPresswire.com⁩/ -- The European Central Bank...

Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity Markets

Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity Markets

HAIFA, Israel, and GEORGE TOWN, Cayman Islands, June 25, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing what it believes to be first-in-class therapies to treat...

Patria Announces Second Quarter 2025 Investor Call

Patria Announces Second Quarter 2025 Investor Call

GRAND CAYMAN, Cayman Islands, July 08, 2025 (GLOBE NEWSWIRE) -- Patria (Nasdaq:PAX) announced today that it will release financial results for the second quarter 2025 on Friday, August 1, 2025, and host a conference call via public webcast at 9:00...

Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.

Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.

XI’AN, China, June 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“Bon” or the “Company”), a leading bio-ingredient solutions provider for natural, health, and personal care industries, today announced a non-exclusive sales...

Tariff Tensions in ASEAN: How Vietnam, Indonesia, and Thailand Are Navigating Trade Headwinds

Tariff Tensions in ASEAN: How Vietnam, Indonesia, and Thailand Are Navigating Trade Headwinds

EBC Financial Group analyses as Southeast Asia faces tough choices as U.S. tariff threats loom large. DC, UNITED STATES, July 25, 2025 /⁨EINPresswire.com⁩/ -- As the U.S. intensifies its protectionist stance under President Trump’s administration,...

Tariff Tensions in ASEAN: How Vietnam, Indonesia, and Thailand Are Navigating Trade Headwinds

Tariff Tensions in ASEAN: How Vietnam, Indonesia, and Thailand Are Navigating Trade Headwinds

EBC Financial Group analyses as Southeast Asia faces tough choices as U.S. tariff threats loom large. DC, UNITED STATES, July 25, 2025 /⁨EINPresswire.com⁩/ -- As the U.S. intensifies its protectionist stance under President Trump’s administration,...

Tariff Tensions in ASEAN: How Vietnam, Indonesia, and Thailand Are Navigating Trade Headwinds

Tariff Tensions in ASEAN: How Vietnam, Indonesia, and Thailand Are Navigating Trade Headwinds

EBC Financial Group analyses as Southeast Asia faces tough choices as U.S. tariff threats loom large. DC, UNITED STATES, July 25, 2025 /⁨EINPresswire.com⁩/ -- As the U.S. intensifies its protectionist stance under President Trump’s administration,...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions